Darvon, Darvocet Recall Issued Due to Risk of Potentially Fatal Heart Rhythm Abnormalities

Last Updated on June 26, 2017

Investigation Complete

Comments |

At A Glance

This Alert Affects
Patients who have been prescribed Darvon, Darvocet, or generic propoxyphene-containing products.
Studies indicate that propoxyphene, even when taken at the recommended dosage, can increase the risk of abnormal heart rhythms, which have been linked to serious negative effects, including death. Past issues that have been linked to these medications include accidental overdose, suicide, nausea, and vomiting.
Xanodyne Pharmaceuticals and the generic manufacturers of propoxyphene-containing products.
Additional Details
Darvon and Darvocet are brand names for propoxyphene, a prescription pain medication used to relieve mild to moderate pain.
The Darvocet and Darvon recall was issued on November 19, 2010.